Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3257324 | 0.81 | — | — | |
| SCHEMBL114032 | 0.79 | NOS1 (0.41) | NOS1SLC6A3MAPT | |
| SCHEMBL11458947 | 0.77 | NOS1 (0.39) | NOS1SLC6A3 | |
| SCHEMBL115387 | 0.73 | — | — | |
| SCHEMBL10968561 | 0.72 | SLC6A3 (0.38) | NOS1SLC6A3OPRM1MAPT | |
| SCHEMBL22996205 | 0.72 | SLC6A3 (0.37) | NOS1SLC6A3 | |
| SCHEMBL14516134 | 0.72 | OPRM1 (0.40) | NOS1SLC6A3OPRM1 | |
| SCHEMBL5898085 | 0.71 | — | — | |
| SCHEMBL1061839 | 0.71 | — | — | |
| SCHEMBL6626591 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1368029-A4 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | FARRINGTON PHARMACEUTICALS LLC (US) | 2006-02-15 | — | — | EP | disclosed |
| EP-1368029-A2 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | Farrington Pharmaceuticals, LLC (US) | 2003-12-10 | — | — | EP | disclosed |
| WO-2002062301-A2 | METHOD AND COMPOSITION FOR REJUVINATING CELLS, TISSUES, ORGANS, HAIR AND NAILS | FARRINGTON PHARMACEUTICALS, LLC (US) | 2002-08-15 | — | — | WO | disclosed |
| CN-1051546-C | Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents | ASTRA AB (SE) | 2000-04-19 | — | — | CN | disclosed |
| US-5843971-A | 1, 1-BIS (heteroazolyl) alkane derivatives and their use as neuroprotective agents | ASTRA AKTIEBOLAG (SE) | 1998-12-01 | — | — | US | disclosed |
| US-5665747-A | TREATING NERVOUS SYSTEM, PSYCHOLOGICAL, AND BRAIN DISORDERS | ASTRA AKTIEBOLAG (SE) | 1997-09-09 | — | — | US | disclosed |
| CN-1150426-A | Novel 1,1-bis (heteroazolyl) alkane derivatives and their use as neuroprotective agents | ASTRA AB (SE) | 1997-05-21 | — | — | CN | disclosed |
| EP-0765325-A1 | NOVEL 1,1-BIS(HETEROAZOLYL)ALKANE DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE AGENTS | Astra Aktiebolag (SE) | 1997-04-02 | — | — | EP | disclosed |
| US-5545835-A | CHEMICAL INTERMEDIATES FOR PREPARATION OF SUBSTITUTED 2,3-PYRIDINEDICARBOXYLIC ACIDS | AMERICAN CYANAMID COMPANY (US) | 1996-08-13 | — | — | US | disclosed |
| WO-1995033747-A1 | NOVEL 1,1-BIS(HETEROAZOLYL)ALKANE DERIVATIVES AND THEIR USE AS NEUROPROTECTIVE AGENTS | ASTRA AKTIEBOLAG (SE) | 1995-12-14 | — | — | WO | disclosed |
| US-5378843-A | Halogenation, quaternization | AMERICAN CYANAMID COMPANY (US) | 1995-01-03 | — | — | US | disclosed |
| US-5288866-A | Chemical intermediates in the preparation of purity herbicides | AMERICAN CYANAMID COMPANY (US) | 1994-02-22 | — | — | US | disclosed |
| US-4006127-A | Cationic diazacyanine dyestuffs | BAYER AKTIENGESELLSCHAFT (DT) | 1977-02-01 | — | — | US | disclosed |